Patients With Ocular Neuropathic Pain: Description of Pain and Impact on Their Quality of Life

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

19 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-05-04

Study Completion Date

2019-10-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Some patients with dry eye may have severe disabling neuropathic pain. They describe spontaneous pain, dysesthesia, hyperalgesia or even allodynia. It is classical to note an important discordance between the high intensity of the symptoms and the poverty of the clinical signs. These pains are often unrecognized and therefore often not sufficiently treated. A significant impact on patient's quality of life may occur. The concept of ocular neuropathic pain being relatively recent, few studies have focused on the subject at present. Our study aims to shed light on these pains in patients consulting for dry eyes at the Ophthalmological Foundation A. de Rothschild.

The objective of our study is to describe precisely the characteristics of neuropathic eye pain and the visual, general and psychological repercussions in these patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Understanding Risk Factors and Determinants for Neuropathic Pain

NCT02402361

Diabetic Neuropathy

COMPLETED

Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain

NCT01053845

Healthy Volunteers Patients Suffering of Peripheral Neuropathic Pain

COMPLETED PHASE1

Intrathecal Ziconotide Antalgic Efficacy for Severe Refractory Neuropathic

NCT03942848

Severe Refractory Neuropathic Pain Spinal Cord Lesions

UNKNOWN PHASE3

Effect of NRD135S.E1 in Peripheral Neuropathic Pain in Diabetic Patients

NCT02345291

Diabetic Peripheral Neuropathic Pain

COMPLETED PHASE2

Neuropathic Pain Caused by Radiation Therapy

NCT00798083

Neuropathic Pain Secondary to Radiation Therapy

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dry Eye Syndromes Neuralgia Pain Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaires on pain and quality of life

Patients will be asked to complete several questionnaires about their pain and the impact on their quality of life.

They will complete the questionnaires in the ophthalmology consultation room or at home and return it by mail (or present it at the next consultation).

Patients will be asked to complete several questionnaires :

* Questionnaire about the characteristics of ocular neuropathic pain (7 items)
* DEQ-5 (Dry Eye Questionnaire)
* ODI (Ocular Surface Disease Index)
* BPI (Brief Pain Inventory)
* HADS (Hospital Anxiety and Depression Scale)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged 18 years or older,
* Presenting at least one of the following symptoms: spontaneous pain, burning sensation in eye, dysesthesia, allodynia, hyperalgesia
* French language-skills